AdaptHealth (NASDAQ:AHCO) & CompuMed (OTCMKTS:CMPD) Financial Comparison

AdaptHealth (NASDAQ:AHCO) and CompuMed (OTCMKTS:CMPD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and recommmendations for AdaptHealth and CompuMed, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1	2	5	0	2.50
CompuMed	0	0	0	0	0.00

AdaptHealth presently has a consensus price target of $14.29, indicating a potential upside of 46.82%. Given AdaptHealth’s stronger consensus rating and higher possible upside, equities analysts clearly believe AdaptHealth is more favorable than CompuMed.

Insider & Institutional Ownership

82.7% of AdaptHealth shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by insiders. Comparatively, 22.0% of CompuMed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares AdaptHealth and CompuMed”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.28 billion	0.40	-$70.79 million	($0.62)	-15.69
CompuMed	$7.55 million	1.15	-$60,000.00	($0.15)	-43.33

CompuMed has lower revenue, but higher earnings than AdaptHealth. CompuMed is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AdaptHealth and CompuMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
CompuMed	-2.51%	-6.47%	-4.18%

Volatility and Risk

AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, CompuMed has a beta of -0.5, indicating that its share price is 150% less volatile than the S&P 500.

Summary

AdaptHealth beats CompuMed on 10 of the 14 factors compared between the two stocks.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

About CompuMed

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.